Bone engineering in dog mandible: Coculturing mesenchymal stem cells with endothelial progenitor cells in a composite scaffold containing vascular endothelial growth factor

Abstract

We sought to assess the effects of coculturing mesenchymal stem cells (MSCs) and endothelial progenitor cells (EPCs) in the repair of dog mandible bone defects. The cells were delivered in β-tricalcium phosphate scaffolds coated with poly lactic co-glycolic acid microspheres that gradually release vascular endothelial growth factor (VEGF). The complete scaffold and five partial scaffolds were implanted in bilateral mandibular body defects in eight beagles. The scaffolds were examined histologically and morphometrically 8 weeks after implantation. Histologic staining of the decalcified scaffolds demonstrated that bone formation was greatest in the VEGF/MSC scaffold (63.42 ± 1.67), followed by the VEGF/MSC/EPC (47.8 ± 1.87) and MSC/EPC (45.21 ± 1.6) scaffolds, the MSC scaffold (34.59 ± 1.49), the VEGF scaffold (20.03 ± 1.29), and the untreated scaffold (7.24 ± 0.08). Hence, the rate of new bone regeneration was highest in scaffolds containing MSC, either mixed with EPC or incorporating VEGF. Adding both EPC and VEGF with the MSC was not necessary. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 105B: 1767-1777, 2017.

Nanocomposite scaffold seeded with mesenchymal stem cells for bone repair

“…In a study conducted by Khojasteh et al () minimum amount of bone formation was reported in the blank scaffold group. In that study, adding mesenchymal cells to scaffolds improved the bone formation.…”

Dextran hydrogels incorporated with bioactive glass-ceramic: Nanocomposite scaffolds for bone tissue engineering

“…There are many topics today that attract attention to bone tissue engineering, such as the everincreasing life expectancy, prevalence of bone defect and issues associated with biological grafts including extra surgery, increase the risk of morbidity, blood loss, sepsis and pain (in autografts) and increasing risk of rejection due to carrying histocompatibility antigens different from the host (in allografts and xenografts) (Horner et al, 2010). Bone tissue engineering, as an alternative therapeutic method for reconstructing native tissue inside the body, uses a temporary and porous 3D scaffold for the delivery and integration of cells and/or growth factors at the repair site (Khojasteh et al, 2017;Mozafari, Mehraien, Vashaee, & Tayebi, 2012;Razavi et al, 2014). These scaffolds are usually fabricated from bioresorbable and bioactive materials, which have the potential to support and stimulate the regeneration of living tissue (Jazayeri et al, 2017;Razavi et al, 2014;Yazdimamaghani et al, 2013).…”

Tissue engineering applications in otolaryngology—The state of translation

“…Heatmap representing the proportion of publications by year that utilized specific translational research methodologies from construct characterization to human trial to investigate craniofacial tissue engineering 49‐72,74‐77,79,81‐84,145‐197 …”